Literature DB >> 25680499

Hepatotoxicity of herbal and dietary supplements: an update.

Felix Stickel1, Daniel Shouval.   

Abstract

Herbal and dietary supplements (HDS) have been used for health-related purposes since more than 5000 years, and their application is firmly anchored in all societies worldwide. Over last decades, a remarkable renaissance in the use of HDS can be noticed in affluent societies for manifold reasons. HDS are forms of complementary and alternative medicines commonly used to prevent or treat diseases, or simply as a health tonic. Another growing indication for HDS is their alleged benefit for weight loss or to increase physical fitness. Access is easy via internet and mail-order pharmacies, and their turnover reaches billions of dollars in the USA and Europe alone. However, HDS are generally not categorized as drugs and thus less strictly regulated in most countries. As a result, scientific evidence proving their beneficial effects is mostly lacking, although some HDS may have purported benefits. However, the majority lacks such proof of value, and their use is predominantly based on belief and hope. In addition to missing scientific evidence supporting their use, HDS are typically prone to batch-to-batch variability in composition and concentration, contamination, and purposeful adulteration. Moreover, numerous examples of preparations emerged which have been linked to significant liver injury. These include single ingredients, such as kava, germander, and several Chinese herbals. Other HDS products associated with liver toxicity consist of multiple, often ill-defined ingredients, such as Hydroxycut and Herbalife. Affirmative diagnostic tests are not available, and the assessment of liver injury ascribed to HDS depends on a thorough and proactive medical history, careful exclusion of other causes, and a search for available reports on similar events linked to the intake of the suspected preparation or ingredients contained therein.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25680499     DOI: 10.1007/s00204-015-1471-3

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  29 in total

1.  Supplements and Hepatotoxicity.

Authors:  K Rajender Reddy
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-07

2.  Herbal Products and Dietary Supplements: A Cross-Sectional Survey of Use, Attitudes, and Knowledge Among the Lebanese Population.

Authors:  Ghada El Khoury; Wijdan Ramadan; Nadine Zeeni
Journal:  J Community Health       Date:  2016-06

Review 3.  Hepatotoxicity by Dietary Supplements: A Tabular Listing and Clinical Characteristics.

Authors:  Miren García-Cortés; Mercedes Robles-Díaz; Aida Ortega-Alonso; Inmaculada Medina-Caliz; Raul J Andrade
Journal:  Int J Mol Sci       Date:  2016-04-09       Impact factor: 5.923

4.  Herb-Induced Liver Injury in the Berlin Case-Control Surveillance Study.

Authors:  Antonios Douros; Elisabeth Bronder; Frank Andersohn; Andreas Klimpel; Reinhold Kreutz; Edeltraut Garbe; Juliane Bolbrinker
Journal:  Int J Mol Sci       Date:  2016-01-15       Impact factor: 5.923

Review 5.  Drug-Induced Liver Toxicity and Prevention by Herbal Antioxidants: An Overview.

Authors:  Divya Singh; William C Cho; Ghanshyam Upadhyay
Journal:  Front Physiol       Date:  2016-01-26       Impact factor: 4.566

6.  Drug-induced liver injury associated with Complementary and Alternative Medicine: a review of adverse event reports in an Asian community from 2009 to 2014.

Authors:  Desmond Chun Hwee Teo; Patricia Suet Leng Ng; Siew Har Tan; Adena Theen Lim; Dorothy Su Lin Toh; Sui Yung Chan; Han Hui Cheong
Journal:  BMC Complement Altern Med       Date:  2016-07-07       Impact factor: 3.659

Review 7.  Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature.

Authors:  Philip Sarges; Joshua M Steinberg; James H Lewis
Journal:  Drug Saf       Date:  2016-09       Impact factor: 5.228

8.  Oroxylum indicum extract, at a physiologically relevant dosage, does not induce hepatotoxicity in C57BL/6J mice.

Authors:  Satyanarayana R Pondugula; Julia M Salamat; Kodye L Abbott; Patrick C Flannery; Mohammed Majrashi; Mohammed Almaghrabi; Manoj Govindarajulu; Sindhu Ramesh; Suneel K Onteru; Maninder Sandey; Chen-Che Huang; Kristina Gill; Natasha Narayanan; Edwin McElroy; Darshini Desai; Rishi Nadar; Timothy Moore; Kalyanam Nagabhushanam; Muhammed Majeed; Muralikrishnan Dhanasekaran
Journal:  Nat Prod Commun       Date:  2021-05-18       Impact factor: 1.496

9.  Methods for estimating causal relationships of adverse events with dietary supplements.

Authors:  Kazuki Ide; Hiroshi Yamada; Mamoru Kitagawa; Yohei Kawasaki; Yuma Buno; Kumi Matsushita; Masayuki Kaji; Kazuko Fujimoto; Masako Waki; Mitsuyoshi Nakashima; Keizo Umegaki
Journal:  BMJ Open       Date:  2015-11-25       Impact factor: 2.692

10.  Prevalence of medication discrepancies in patients with cirrhosis: a pilot study.

Authors:  Kelly L Hayward; Patricia C Valery; W Neil Cottrell; Katharine M Irvine; Leigh U Horsfall; Caroline J Tallis; Veronique S Chachay; Brittany J Ruffin; Jennifer H Martin; Elizabeth E Powell
Journal:  BMC Gastroenterol       Date:  2016-09-13       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.